The DOI matches its Crossref record.
A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1-34 in Treatment of Hypoparathyroidism
Open accessAbstract
Once-daily sc injection of PTH 1-34 can normalize mean serum and urine calcium levels in patients with hypoparathyroidism; however, once-daily PTH has diminishing effects on serum calcium after 12 h, such that serum calcium levels fall below the normal range in some patients. Once-daily PTH also causes a marked increase in bone turnover, with persistent increases in markers of bone formation and resorption. To test the hypothesis that a twice-daily PTH regimen can produce more physiological control than a once-daily regimen, we performed a randomized cross-over trial, lasting 28 weeks, in 17 adult subjects with hypoparathyroidism. Each 14-week study arm was divided into a 2-week inpatient dose-adjustment phase and a 12-week outpatient phase. The PTH dose (given sc once daily at 0900 h or twice daily with one dose at 0900 h and the other at 2100 h) was adjusted to maintain both serum and urine calcium within, or close to, the normal range. During the second half of the day (12-24 h), twice-daily PTH increased serum calcium and magnesium levels more effectively than once-daily PTH. In patients with calcium receptor mutations (CaR), once-daily PTH normalized urine calcium, provided that serum calcium was maintained at levels below normal range. However, twice-daily PTH treatment produced higher mean serum calcium in patients with CaR with no significant rise in urine calcium excretion, and with no significant differences in either serum or urine calcium levels between CaR and patients with acquired or idiopathic hypoparathyroidism. Thus, treatment with twice-daily PTH is the better regimen for patients with CaR to overcome their tendency to hypercalciuria while producing near-normal levels of serum calcium. The total daily PTH dose was markedly reduced with the twice-daily regimen (twice daily 46+/-52 vs. once daily 97+/-60 microg/day, P < 0.001). We conclude that a twice-daily PTH regimen provides effective treatment of hypoparathyroidism and reduces the variation in serum calcium levels at a lower total daily PTH dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bilezikian, J. P., Khan, A., Potts, J. T., Brandi, M. L., Clarke, B. L., Shoback, D., Jüppner, H., D'Amour, P., Fox, J., Rejnmark, L., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.483 · Cited by 617
Management of Hypoparathyroidism: Summary Statement and Guidelines
Brandi, M. L., Bilezikian, J. P., Shoback, D., Bouillon, R., Clarke, B. L., Thakker, R. V., Khan, A. A., & Potts, J. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3907 · Cited by 436
Long-Term Follow-Up of Patients with Hypoparathyroidism
Mitchell, D. M., Regan, S., Cooley, M. R., Lauter, K. B., Vrla, M. C., Becker, C. B., Burnett-Bowie, S.-A. M., & Mannstadt, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1808 · Cited by 402
Presentation of Hypoparathyroidism: Etiologies and Clinical Features
Shoback, D. M., Bilezikian, J. P., Costa, A. G., Dempster, D., Dralle, H., Khan, A. A., Peacock, M., Raffaelli, M., Silva, B. C., Thakker, R. V., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3909 · Cited by 371
Sikjaer, T., Rolighed, L., Hess, A., Fuglsang-Frederiksen, A., Mosekilde, L., & Rejnmark, L. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2677-6 · Cited by 134
Metadata
- Authors
- Winer, K. K.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-10-01
- Volume
- 83
- Issue
- 10
- Pages
- 3480-3486
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2132782676
- Cited by
- 189
- References
- 0
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1-34 in Treatment of Hypoparathyroidism. https://app.cochat.ai/papers/10.1210/jc.83.10.3480
- The paper
- Winer, K. K. (1998). A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1-34 in Treatment of Hypoparathyroidism. Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.83.10.3480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.